Advanced Enzyme Technologies share news, announcements and annual reports
NSE: ADVENZYMESBSE: 540025Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹264.15.
30 Oct: open ₹266.00, high ₹268.05, low ₹259.50
- Next results date: the board meets on 31 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,929 Cr912th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 17.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.51%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,81,29158.4% delivered
Advanced Enzyme Technologies has 738 announcements on record, routine notices left out; 13 in the 30 days to 31 Oct 2026, the latest on 30 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Advanced Enzyme Technologies quarterly results
The board meets on 31 Oct 2026 to consider financial results
Notice filed 23 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Advanced Enzyme Technologies annual reports, presentations and earnings calls
The company's own documents, latest first.Advanced Enzyme Technologies financials, year by year
Annual reports11
- Annual report, year to Mar 20268 Jul 2026
- Annual report, year to Mar 20253 Jul 2025
- Annual report, year to Mar 20241 Jul 2024
- Annual report, year to Mar 202313 Jul 2023, a zip file
- Annual report, year to Mar 202227 Jul 2022, a zip file
6 earlier reports
- Annual report, year to Mar 202116 Aug 2021, a zip file
- Annual report, year to Mar 202022 Jun 2020, a zip file
- Annual report, year to Mar 201912 Jul 2019, a zip file
- Annual report, year to Mar 201829 Sep 2018, a zip file
- Annual report, year to Mar 201712 Sep 2017, a zip file
- Annual report, year to Mar 201616 Sep 2016, a zip file
Investor presentations51
- Investor Presentation8 Aug 2026
- Investor Presentation9 May 2026
- Investor Presentation31 Jan 2026
- Investor Presentation12 Nov 2025
- Investor Presentation22 Sep 2025
46 earlier presentations
- Investor Presentation2 Aug 2025
- Investor Presentation13 May 2025
- Investor Presentation8 Feb 2025
- Investor Presentation9 Nov 2024
- Investor Presentation10 Aug 2024
- Investor Presentation11 May 2024
- Investor Presentation10 Feb 2024
- Investor Presentation7 Nov 2023
- Investor Presentation13 May 2023
- Investor Presentation11 Feb 2023
- Earnings Presentation for the quarter ended September 30, 202211 Nov 2022
- Earnings Presentation for the quarter ended June 30, 20226 Aug 2022
- Investor Presentation20 May 2022
- Investor Presentation5 Feb 2022
- Investor Presentation2 Nov 2021
- Investor Presentation2 Nov 2021
- Investor Presentation1 Oct 2021
- Investor Presentation7 Aug 2021
- Investor Presentation31 May 2021
- Investor Presentation12 Feb 2021
- Investor Presentation In furtherance of the letter dated December 27, 2020 intimating the approval of the Board to acquire controlling stake (51%) in SciTech Specialities Private Limited, enclosed is the Investor Presentation in this regard.30 Dec 2020
- Investor Presentation12 Nov 2020
- Investor Presentation revised one.12 Aug 2020
- Investor Presentation12 Aug 2020
- Investor Presentation30 May 2020
- Investor Presentation - Revised6 Feb 2020
- Investor Presentation6 Feb 2020
- Investor Presentation- Revised Earnings Presentation, with slight change in slide no. 7 (in PAT Q2FY20)2 Nov 2019
- Investor Presentation2 Nov 2019
- Investor Presentation10 Aug 2019
- Investor Presentation for May 201927 May 2019
- Investor Presentation1 Nov 2018
- Investor Presentation11 Aug 2018, a zip file
- Investor Presentation June 201822 Jun 2018, a zip file
- Investor Presentation21 May 2018, a zip file
- Investor Presentation19 May 2018, a zip file
- Investor Presentation6 Feb 2018, a zip file
- Investor Presentation14 Nov 2017, a zip file
- Investor Presentation25 Sep 2017, a zip file
- Investor Presentation11 Sep 2017, a zip file
- Investor Presentation5 Jun 2017, a zip file
- Investor Presentation3 Jun 2017, a zip file
- Investor Presentation27 May 2017, a zip file
- Investor Presentation3 Mar 2017, a zip file
- Investor Presentation21 Feb 2017, a zip file
- Investor Presentation14 Nov 2016, a zip file
Earnings calls48
- Transcript18 Aug 2026
- Link of Recording12 Aug 2026
- Transcript15 May 2026
- Link of Recording12 May 2026
- Transcript7 Feb 2026
43 earlier call documents
- Link of Recording4 Feb 2026
- Transcript17 Nov 2025
- Link of Recording13 Nov 2025
- Transcript11 Aug 2025
- Link of Recording6 Aug 2025
- Transcript19 May 2025
- Link of Recording14 May 2025
- Transcript17 Feb 2025
- Link of Recording12 Feb 2025
- Transcript19 Nov 2024
- Link of Recording13 Nov 2024
- Transcript16 Aug 2024
- Link of Recording13 Aug 2024
- Transcript21 May 2024
- Link of Recording15 May 2024
- Transcript21 Feb 2024
- Link of Recording16 Feb 2024
- Transcript17 Nov 2023
- Link of Recording11 Nov 2023
- Transcript23 Aug 2023
- Link of Recording16 Aug 2023
- In furtherance to our intimation letter dated May 12, 2023, please find enclosed the Transcript of the Conference call held on Monday, May 15, 2023 with Analysts and Investors for the audited Financial Results of the Company for the quarter and year ended March 31, 2023.18 May 2023
- Link of Recording15 May 2023
- Furtherance to our intimation letter dated February 07, 2023, please find enclosed the Transcript of the Conference call held on Tuesday, February 14, 2023 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2022.17 Feb 2023
- Link of Recording14 Feb 2023
- Furtherance to our intimation letter dated November 08, 2022, please find enclosed the Transcript of the Conference call held on Tuesday, November 15, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2022.21 Nov 2022
- Audio recording of Conference call held today i.e. on Tuesday, November 15, 2022 on the Un-audited Financial Results for the quarter and half year ended September 30, 202215 Nov 2022
- Furtherance to our intimation letter dated August 02, 2022, please find enclosed the Transcript of the Conference call held on Saturday, August 06, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter ended June 30, 2022.9 Aug 2022
- Audio recording of Conference call held today i.e. on Saturday, August 06, 2022 on the Un-audited Financial Results for the quarter ended June 30, 20226 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call27 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call23 May 2022
- Transcript12 Feb 2022
- Transcript of the Conference call held on Wednesday, November 03, 2021 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2021.8 Nov 2021
- .Transcript of Conference call held on August 11, 2021 for Un-audited financial results for the quarter ended June 30, 202114 Aug 2021
- Transcript of Conference call held on May 31, 2021 for annual financial results for thequarter and year ended March 31, 20213 Jun 2021
- Transcript of Earnings Conference Call for Q3FY21 and 9MFY2121 Feb 2021
- Earning Conference Call Transcript for Q2 FY2021 & H1 FY202117 Nov 2020
- Transcript of Earnings Conference Call for Q4 FY 20205 Jun 2020
- Analysts/Institutional Investor Meet/Con. Call Updates- Earning Call Transcripts Q4 FY 1930 May 2019
- Earnings Call Transcript16 Nov 2017, a zip file
- Transcript of FY17 Earning conference call.1 Jun 2017, a zip file
- Transcript of Advanced Enzyme Technologies Limited 3QFY17 Results Conference Call.17 Feb 2017, a zip file
- Transcript of Conference Call held on October 28, 20162 Nov 2016, a zip file
Advanced Enzyme Technologies merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings1
- Amalgamation/Merger11 Feb 2023
Advanced Enzyme Technologies share news and announcements
Newest first. Page 1 of 15.
Oct 2026
30 Oct · Updates
28 Oct · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
26 Oct · Analysts
23 Oct · Board meeting
21 Oct · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
16 Oct · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
13 Oct · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
7 Oct · Updates
5 Oct · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
1 Oct · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Sep 2026
30 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
25 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
24 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
23 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
22 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
21 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
15 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
11 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
8 Sep · Updates
3 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
2 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
1 Sep · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Aug 2026
31 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
28 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
27 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
25 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
24 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
21 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
20 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
19 Aug · Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
13 Aug
11 Aug · Buyback
8 Aug · Board meeting
8 Aug · Results
4 Aug · Analysts
1 Aug
1 Aug · Board meeting
Jul 2026
31 Jul · Meeting
8 Jul · General Updates
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 29 Oct 2026Buybackup 1.69%+0.7 pts vs Nifty 500market median 0.0% · volume 1.2× usual · delivery −10.1 pts against usual · The announcement
- 22 Oct 2026Buybackdown 0.04%+0.6 pts vs Nifty 500market median 0.0% · five sessions +0.3% (+0.8 pts vs Nifty 500) · volume 1.1× usual · delivery −8.2 pts against usual · The announcement
- 19 Oct 2026Buybackdown 1.87%−0.8 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−2.6 pts vs Nifty 500) · volume 1.0× usual · delivery −5.7 pts against usual · The announcement
- 14 Oct 2026Buybackup 0.32%+0.6 pts vs Nifty 500market median 0.0% · five sessions −3.1% (−2.0 pts vs Nifty 500) · volume 0.9× usual · delivery +10.0 pts against usual · The announcement
- 6 Oct 2026Buybackup 0.26%−0.8 pts vs Nifty 500market median 0.0% · five sessions −2.1% (−1.4 pts vs Nifty 500) · volume 0.8× usual · delivery +6.6 pts against usual · The announcement
- 5 Oct 2026Buybackdown 0.67%−1.2 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−2.6 pts vs Nifty 500) · volume 0.7× usual · delivery −3.5 pts against usual · The announcement
- 1 Oct 2026Buybackdown 2.61%−1.6 pts vs Nifty 500market median 0.0% · five sessions −5.9% (−3.9 pts vs Nifty 500) · volume 1.1× usual · delivery −4.3 pts against usual · The announcement
- 28 Sep 2026Buybackdown 2.75%−1.1 pts vs Nifty 500market median 0.0% · five sessions −6.4% (−3.6 pts vs Nifty 500) · volume 0.8× usual · delivery +7.5 pts against usual · The announcement
- 25 Sep 2026Buybackdown 0.55%−0.8 pts vs Nifty 500market median 0.0% · five sessions −6.3% (−3.2 pts vs Nifty 500) · volume 0.9× usual · delivery +2.2 pts against usual · The announcement
- 24 Sep 2026Buybackdown 1.43%+0.2 pts vs Nifty 500market median 0.0% · five sessions −5.2% (−1.4 pts vs Nifty 500) · volume 1.0× usual · delivery −7.3 pts against usual · The announcement
20 earlier announcements
- 23 Sep 2026Buybackup 0.13%−0.5 pts vs Nifty 500market median 0.0% · five sessions −4.9% (−1.8 pts vs Nifty 500) · volume 1.0× usual · delivery −4.1 pts against usual · The announcement
- 22 Sep 2026Buybackup 0.87%+1.2 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−1.0 pts vs Nifty 500) · volume 1.2× usual · delivery −10.8 pts against usual · The announcement
- 16 Sep 2026Buybackup 0.05%−0.2 pts vs Nifty 500market median 0.0% · five sessions +3.1% (+1.7 pts vs Nifty 500) · volume 0.8× usual · delivery −5.3 pts against usual · The announcement
- 15 Sep 2026Buybackdown 1.94%−0.2 pts vs Nifty 500market median 0.0% · five sessions +0.2% (+0.2 pts vs Nifty 500) · volume 1.1× usual · delivery −1.0 pts against usual · The announcement
- 4 Sep 2026Buybackdown 0.95%−0.9 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+3.8 pts vs Nifty 500) · volume 0.9× usual · delivery +0.1 pts against usual · The announcement
- 3 Sep 2026Buybackup 1.06%+0.9 pts vs Nifty 500market median 0.0% · five sessions +2.3% (+3.4 pts vs Nifty 500) · volume 0.4× usual · delivery −5.1 pts against usual · The announcement
- 2 Sep 2026Buybackdown 0.83%−0.3 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+2.2 pts vs Nifty 500) · volume 0.7× usual · delivery +6.6 pts against usual · The announcement
- 1 Sep 2026Buybackup 0.43%+0.9 pts vs Nifty 500market median 0.0% · five sessions +1.3% (+2.5 pts vs Nifty 500) · volume 0.6× usual · delivery +5.8 pts against usual · The announcement
- 31 Aug 2026Buybackdown 1.90%−1.6 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−1.0 pts vs Nifty 500) · volume 0.5× usual · delivery +12.0 pts against usual · The announcement
- 28 Aug 2026Buybackup 0.74%+0.5 pts vs Nifty 500market median 0.0% · five sessions −0.5% (+0.4 pts vs Nifty 500) · volume 0.5× usual · delivery +0.4 pts against usual · The announcement
- 26 Aug 2026Buybackdown 0.85%−0.6 pts vs Nifty 500market median 0.0% · five sessions −1.5% (−0.3 pts vs Nifty 500) · volume 0.5× usual · delivery −4.8 pts against usual · The announcement
- 25 Aug 2026Buybackdown 0.86%−1.3 pts vs Nifty 500market median 0.0% · five sessions −2.7% (−2.5 pts vs Nifty 500) · volume 0.6× usual · delivery −3.7 pts against usual · The announcement
- 24 Aug 2026Buybackup 0.78%+0.9 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−0.1 pts vs Nifty 500) · volume 0.4× usual · delivery −9.1 pts against usual · The announcement
- 21 Aug 2026Buybackdown 0.99%−1.1 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−1.7 pts vs Nifty 500) · volume 1.3× usual · delivery +4.6 pts against usual · The announcement
- 20 Aug 2026Buybackdown 0.72%−1.3 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−3.4 pts vs Nifty 500) · volume 0.8× usual · delivery +1.1 pts against usual · The announcement
- 12 Aug 2026Buybackup 1.12%+1.2 pts vs Nifty 500market median 0.0% · five sessions +1.6% (+2.5 pts vs Nifty 500) · volume 1.3× usual · delivery −10.7 pts against usual · The announcement
- 10 Aug 2026Resultsdown 9.19%−9.3 pts vs Nifty 500market median −0.7% · five sessions −6.2% (−5.7 pts vs Nifty 500) · volume 4.5× usual · delivery +1.6 pts against usual · The announcement
- 11 May 2026Resultsup 9.28%+10.7 pts vs Nifty 500market median −0.7% · five sessions +1.8% (+4.3 pts vs Nifty 500) · volume 23.8× usual · delivery −43.8 pts against usual · The announcement
- 7 May 2026Credit ratingup 1.10%+0.7 pts vs Nifty 500market median 0.0% · five sessions +3.4% (+6.6 pts vs Nifty 500) · volume 0.5× usual · delivery −1.0 pts against usual · The announcement
- 10 Apr 2026Board or managers changedup 1.97%+0.6 pts vs Nifty 500market median 0.0% · five sessions +5.3% (+1.6 pts vs Nifty 500) · volume 1.2× usual · delivery +6.9 pts against usual · The announcement
Advanced Enzyme Technologies results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.